6-Chlorohex-1-ene | CAS:928-89-2

We serve 6-Chlorohex-1-ene CAS:928-89-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
6-Chlorohex-1-ene

Chemical Name:6-Chlorohex-1-ene
CAS.NO:928-89-2
Synonyms:
6-chloro-hexene
1-chloro-5-hexene
6-chloro-hex-1-ene
5-hexenyl chloride
6-Chloro-1-hexene
 
Molecular Formula: C6H11Cl
Molecular Weight:118.60500
 
Physical and Chemical Properties:
Density:0.896g/cm3
Boiling point:135-136ºC
Melting point:/
Flash point:29ºC
Index of Refraction:1.438
 
Specification:
Appearance:Colorless transparent liquid
Purity:≥97.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a dry, inert atmosphere, keep container sealed and store in a cool, dry place
Application:Pharmaceutical intermediate



Contact us for information like 6-Chlorohex-1-ene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Chloro-1-hexene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-hexenyl chloride Use and application,6-Chlorohex-1-ene technical grade,usp/ep/jp grade.


Related News: Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.Ethyl chloroacetate manufacturer Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.Dichlorodiphenylsilane supplier An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.N-Methyl-4-nitroaniline vendor On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.